Skip to content

Clinical trials

Terminated Phase 1/2 trials in Norway

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 1/2 Status: Terminated Country / region: Norway Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20091
20111
20151
20161
20172
20182
20191
20202

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated12

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Oslo University Hospital2
Steinar Aamdal2
Bristol-Myers Squibb1
Merck Sharp & Dohme LLC1
Mundipharma-EDO GmbH1
Norwegian University of Science and Technology1
Novartis Pharmaceuticals1
Rikshospitalet University Hospital1
Spur Therapeutics1
Teva Branded Pharmaceutical Products R&D LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung1
Carcinoma, Ovarian Epithelial1
Colorectal Neoplasms1
Fabry Disease1
Fibrosis1
Headache Disorders1
Lysosomal Storage Diseases1
Melanoma1
Multiple Myeloma1
Neoplasm Metastasis1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.